Autoimmune necrotising myopathy (Q84062): Difference between revisions

@@ description / pt-br / description / pt-br @@
+Apresenta fraqueza muscular proximal ocorrendo durante ou após o tratamento com estatinas; frequentemente associada com elevação da creatinoquinase (CK) sérica. A fraqueza muscular pode persistir, após a interrupção do tratamento com estatinas. Neuropatologicamente dá evidências de miopatia necrosante com inflamação escassa. Pode ser necessária terapia imunossupressora._x000D_ _x000D_ Os autoanticorpos neurais associados são anti-SRP (anticorpo de partícula de reconhecimento de sinal) e anti HMGCR (autoanticorpos que reconhecem 3-hidroxi-3-metilglutaril-coenzima A redutase)
@@ description / en / description / en @@
+Presents with proximal muscle weakness occurring during or after treatment with statins; often associated with elevated serum creatine kinase (CK). The muscle weakness can persist, after discontinuation of statin treatment. Neuropathologically gives evidence of necrotizing myopathy with scarce inflammation. Immune suppressive therapy may be needed. Associated neural autoantibodies are Anti- SRP (signal recognition particle antibody) and anti HMGCR (Autoantibodies recognizing 3-hydroxy-3-methylglutaryl-coenzyme A reductase)
@@ Property / Canonical URI @@
+https://id.who.int/icd/entity/1655474050
@@ Property / Canonical URI: https://id.who.int/icd/entity/1655474050 / rank @@
+Normal rank
@@ Property / CURIE @@
+CID11:ID_1655474050
@@ Property / CURIE: CID11:ID_1655474050 / rank @@
+Normal rank
@@ Property / Canary Token @@
+dki-india-ID_1655474050
@@ Property / Canary Token: dki-india-ID_1655474050 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 13 August 2026 / rank @@
+Normal rank

Latest revision as of 09:25, 15 August 2026

Presents with proximal muscle weakness occurring during or after treatment with statins; often associated with elevated serum creatine kinase (CK). The muscle weakness can persist, after discontinuation of statin treatment. Neuropathologically gives evidence of necrotizing myopathy with scarce inflammation. Immune suppressive therapy may be needed. Associated neural autoantibodies are Anti- SRP (signal recognition particle antibody) and anti HMGCR (Autoantibodies recognizing 3-hydroxy-3-methylglutaryl-coenzyme A reductase)

Language	Label	Description	Also known as
default for all languages	ID_1655474050
English	Autoimmune necrotising myopathy	Presents with proximal muscle weakness occurring during or after treatment with statins; often associated with elevated serum creatine kinase (CK). The muscle weakness can persist, after discontinuation of statin treatment. Neuropathologically gives evidence of necrotizing myopathy with scarce inflammation. Immune suppressive therapy may be needed. Associated neural autoantibodies are Anti- SRP (signal recognition particle antibody) and anti HMGCR (Autoantibodies recognizing 3-hydroxy-3-methylglutaryl-coenzyme A reductase)